Replication, Fine-Mapping and Sequencing: Follow-Up on Genome-Wide Association Studies for Arthritis and Musculoskeletal and Skin Diseases (R01)

Post Date

March 20th 2009

Application Due Date

June 29th 2011

Funding Opportunity Number

PAR-09-135

CFDA Number(s)

93.846

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Estimated Total Funding:

  $1500000

• Award Range:

  $None - $250000

Grant Description

Purpose. This Funding Opportunity Announcement (FOA), issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, encourages applications that propose to perform replication, fine-mapping, and sequencing studies of human genomic regions that are putatively associated with phenotypes relevant to the NIAMS mission. Genomic regions of interest are primarily those identified by genome-wide association studies (GWAS). The objective of this FOA is to enhance the identification of causal genes and genetic variants that influence complex diseases relevant to the NIAMS mission. Replication, fine-mapping, and sequencing studies are to be conducted in existing cohorts with defined phenotypes. This FOA will not support recruitment of human subjects, collection of medical or phenotypic data, studies using animal models, or the initial discovery phase of GWAS. Mechanism of Support. This FOA will utilize the NIH Research Project (R01) grant mechanism. In some instances, an active NIAMS R01 award may currently support a GWAS with a two-stage design, including initial discovery and replication. In such instances, investigators may submit a revision (formerly competing supplement) application in response to this FOA, to support additional replication, fine-mapping, or sequencing efforts, provided the application conforms to both the budgetary requirements of this FOA and the format requirements of revision applications. Funds Available and Anticipated Number of Awards. For this funding opportunity, the NIAMS expects to commit approximately $1.5 million total costs in each of fiscal years 2010, 2011, and 2012, to support three to four new projects per year. Budgets up to $250,000 direct costs per year and project periods of up to two years may be requested. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/pa-files/PAR-09-135.html